Concepedia

Runyan Jin

RJ

Statistics

Publications

3

Citations

229

H-Index

3

Active since

2015

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Runyan Jin is an author at Center for Drug Evaluation and Research specializing in oncology pharmacotherapy, medicine, and oncology.

Publications per year

2015–2023

3

Publications

3

FDA Approval Summary: Ramucirumab for Gastric Cancer

Sandra J. Casak, Ibilola Fashoyin-Aje, Steven J. Lemery et al. · Clinical Cancer Research · 2015 · 100 citations

, , +12

FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma

Meredith K. Chuk, Jennie Chang, Marc R. Theoret et al. · Clinical Cancer Research · 2017 · 89 citations

, , +17

US Food and Drug Administration Approval Summary: Nivolumab Plus Platinum-Doublet Chemotherapy for the Neoadjuvant Treatment of Patients With Resectable Non–Small-Cell Lung Cancer

Oladimeji Akinboro, Nicole Drezner, Anup Amatya et al. · Journal of Clinical Oncology · 2023 · 40 citations · Full text

, , +17

1–3 of 3